Tetrakis(2,6-diaminopyridinium) diphthalate 2,6-diaminopyridine
نویسندگان
چکیده
منابع مشابه
Tetrakis(2,6-diaminopyridinium) diphthalate 2,6-diaminopyridine
In the title compound, 4C(5)H(8)N(3) (+)·2C(8)H(4)O(4) (2-)·C(5)H(7)N(3), the asymmetric unit consists of two protonated diamino-pyridine cations, one phthalate anion and one half of a diamino-pyridine mol-ecule, which has twofold rotation symmetry and is disordered over two positions with a site-occupancy ratio of 0.534 (3):0.466 (3). In the disordered structure, both pyridine rings are essent...
متن کامل3,4-Diaminopyridinium 2-carboxy-4,6-dinitrophenolate
In the title salt, C(5)H(8)N(3) (+)·C(7)H(3)N(2)O(7) (-), the pyridine N atom of the 3,4-diamino-pyridine mol-ecule is protonated. The 3,5-dinitro-salicylate anion shows whole-mol-ecule disorder over two orientations with a refined occupancy ratio of 0.875 (4): 0.125 (4). In the crystal, the cations and anions are connected by inter-molecular N-H⋯O and C-H⋯O hydrogen bonds, forming a three-dime...
متن کاملDiaminopyridine Treatment of Neurological Disorders
The drug 3, 4 diaminopyridine (DAP) is a potassium channel blocker, closely related to 4-aminopyridine. Like 4-AP, DAP blocks the voltage-sensitive potassium channel. However, unlike 4-AP, DAP does not cross the blood brain barrier unless the barrier is broken. DAP therefore should be well suited for treating peripheral demyelination and have less central nervous system mediated side-effects. M...
متن کامل3,4-Diaminopyridine may improve neuromuscular block during botulism
In September 2011, two outbreaks of botulism toxemia (toxin A) incriminating the same artisanal product were responsible for nine cases of botulism in France. Among these cases, three women (Cases 1, 2, and 3) aged 27, 29, and 23 years, respectively, were hospitalized in our ICU for mechanical ventilation support. They rapidly received a trivalent botulism antitoxin serum. Two weeks later, Case...
متن کامل3,4-Diaminopyridine in the treatment of congenital (hereditary) myasthenia.
Congenital or hereditary myasthenia describes a heterogeneous group of disorders in which the immune system is not implicated. Treatment has previously depended on anticholinesterase medication. The effectiveness of 3,4-diaminopyridine (3,4-DAP), a preparation that enhances acetylcholine release from motor nerve terminals, has been evaluated using a series of standardised strength measures. Six...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Acta Crystallographica Section E Structure Reports Online
سال: 2009
ISSN: 1600-5368
DOI: 10.1107/s1600536809044468